Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome

IntroductionAdministering optimal cardiovascular medication (OCM) to patients with hypertension (HBP) and ischemic heart disease (IHD) lowers cardiovascular morbidity and mortality.The main objective of this study was to compare in-hospital cardiac mortality among patients with HBP and/or IHD, treat...

Full description

Bibliographic Details
Main Authors: Călin Pop, Roberta Florescu, Claudia Matei, Lavinia Pop, Viorel Manea, Coralia Cotoraci, Liana Mos, Antoniu Petris
Format: Article
Language:English
Published: Touch Medical Media 2017-10-01
Series:Heart International
Online Access:http://www.heart-int.com/Attach/84719789-A605-4F3E-8D83-E97AFFA73B2F/F215CEC2-F07E-4C07-BCE0-9DA2B5CDD2FF
id doaj-c864068aa8fa4688aff98381bf599887
record_format Article
spelling doaj-c864068aa8fa4688aff98381bf5998872020-11-24T20:59:26ZengTouch Medical MediaHeart International1826-18682036-25792017-10-011210010.5301/heartint.5000237Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndromeCălin PopRoberta FlorescuClaudia MateiLavinia PopViorel ManeaCoralia CotoraciLiana MosAntoniu PetrisIntroductionAdministering optimal cardiovascular medication (OCM) to patients with hypertension (HBP) and ischemic heart disease (IHD) lowers cardiovascular morbidity and mortality.The main objective of this study was to compare in-hospital cardiac mortality among patients with HBP and/or IHD, treated or untreated with OCM, who developed a first episode of acute coronary syndrome (ACS).MethodsThe study was carried out retrospectively and included patients admitted with a first episode of ACS between 2013 and 2016. The patients were divided into three groups: those with HBP, IHD, and a history of HBP + IHD. Patients were then divided into two subgroups: subgroup A consisted of patients undergoing optimal anti-ischemic and/or antihypertensive therapy, while subgroup B consisted of patients without OCM.ResultsThis analysis comprised 1096 patients. Mean age was 64.3 ± 18 years. There were 581 patients in subgroup A – 53%, and 515 patients in subgroup B – 47%. Total cardiac mortality was 9.98%, different depending on the groups and subgroups studied: HBP group total – 7%, subgroup A – 5.1%, significantly lower compared to subgroup B – 9.4% (p = 0.05); IHD group total – 12.2%, subgroup A – 9.07%, significantly lower compared to subgroup B – 15.8% (p = 0.05); HBP + IHD group total – 14.35%, subgroup A – 9.9%, significantly lower compared to subgroup B – 18.8% (p = 0.05).ConclusionsThe lack of OCM in patients with HBP and/or IHD is correlated to a significant increase in in-hospital cardiac mortality among patients who develop a first-episode ACS.http://www.heart-int.com/Attach/84719789-A605-4F3E-8D83-E97AFFA73B2F/F215CEC2-F07E-4C07-BCE0-9DA2B5CDD2FF
collection DOAJ
language English
format Article
sources DOAJ
author Călin Pop
Roberta Florescu
Claudia Matei
Lavinia Pop
Viorel Manea
Coralia Cotoraci
Liana Mos
Antoniu Petris
spellingShingle Călin Pop
Roberta Florescu
Claudia Matei
Lavinia Pop
Viorel Manea
Coralia Cotoraci
Liana Mos
Antoniu Petris
Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome
Heart International
author_facet Călin Pop
Roberta Florescu
Claudia Matei
Lavinia Pop
Viorel Manea
Coralia Cotoraci
Liana Mos
Antoniu Petris
author_sort Călin Pop
title Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome
title_short Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome
title_full Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome
title_fullStr Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome
title_full_unstemmed Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome
title_sort role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome
publisher Touch Medical Media
series Heart International
issn 1826-1868
2036-2579
publishDate 2017-10-01
description IntroductionAdministering optimal cardiovascular medication (OCM) to patients with hypertension (HBP) and ischemic heart disease (IHD) lowers cardiovascular morbidity and mortality.The main objective of this study was to compare in-hospital cardiac mortality among patients with HBP and/or IHD, treated or untreated with OCM, who developed a first episode of acute coronary syndrome (ACS).MethodsThe study was carried out retrospectively and included patients admitted with a first episode of ACS between 2013 and 2016. The patients were divided into three groups: those with HBP, IHD, and a history of HBP + IHD. Patients were then divided into two subgroups: subgroup A consisted of patients undergoing optimal anti-ischemic and/or antihypertensive therapy, while subgroup B consisted of patients without OCM.ResultsThis analysis comprised 1096 patients. Mean age was 64.3 ± 18 years. There were 581 patients in subgroup A – 53%, and 515 patients in subgroup B – 47%. Total cardiac mortality was 9.98%, different depending on the groups and subgroups studied: HBP group total – 7%, subgroup A – 5.1%, significantly lower compared to subgroup B – 9.4% (p = 0.05); IHD group total – 12.2%, subgroup A – 9.07%, significantly lower compared to subgroup B – 15.8% (p = 0.05); HBP + IHD group total – 14.35%, subgroup A – 9.9%, significantly lower compared to subgroup B – 18.8% (p = 0.05).ConclusionsThe lack of OCM in patients with HBP and/or IHD is correlated to a significant increase in in-hospital cardiac mortality among patients who develop a first-episode ACS.
url http://www.heart-int.com/Attach/84719789-A605-4F3E-8D83-E97AFFA73B2F/F215CEC2-F07E-4C07-BCE0-9DA2B5CDD2FF
work_keys_str_mv AT calinpop roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome
AT robertaflorescu roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome
AT claudiamatei roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome
AT laviniapop roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome
AT viorelmanea roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome
AT coraliacotoraci roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome
AT lianamos roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome
AT antoniupetris roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome
_version_ 1716782392186765312